Amulet to sell Synteract to Syneos Health
Amulet Capital Partners has agreed to sell its Synteract, a contract research organization for biotech and pharmaceutical companies.
29 October 2020•3 mins read
Amulet Capital Partners has agreed to sell its Synteract, a contract research organization for biotech and pharmaceutical companies.
Genstar Capital exits Obsidian in sale to Daiichi Life-owned Protective
1 hour ago · 1 min read
EQT Infrastructure-backed SatPort acquires Speedcast’s teleport business, adding 12 sites
1 hour ago · 1 min read
O2 Investment Partners exits Xobee Networks via sale to Sole Source-backed Brite
1 hour ago · 1 min read
Francisco Partners and KKR to take minority stakes in H&F-backed TeamSystem
3 hours ago · 2 mins read
Carlyle and PAI Partners agree to sell Theramex to Cinven
4 hours ago · 1 min read
Hg agrees to back new European AI transformation firm alongside Anthropic
4 hours ago · 1 min read
KKR-backed CIRCOR agrees to acquire Italian pump maker Green Silence Group
4 hours ago · 1 min read
